Clinical Manifestations of Chronic Diabetes

Slide 1 · Clinical Manifestations of Chronic Diabetes

Vascular, renal, ocular, neural, and infectious complications

Clinicopathologic consequences of sustained hyperglycemia

Dr Abu Suraih Sakhri

MBBS, MD (Pathology)

www.abusuraihsakhri.com

Slide 2 · Learning objectives

Explain why cumulative glycemic exposure is central to late diabetic morbidity.

Differentiate macrovascular events from microvascular organ damage.

Relate characteristic kidney, eye, and nerve lesions to clinical manifestations.

Explain how impaired host defense and vascular injury compound infection risk.

Slide 3 · Chronic injury dominates the long-term burden

Long-term complications, rather than acute metabolic crises, account for most diabetes-related morbidity and mortality.

The major targets are blood vessels, renal tissue, retina, peripheral nerves, and host-defense mechanisms.

An apparently stable metabolic state does not exclude progressive tissue injury.

Slide 4 · Time and glycemic exposure determine severity

Sustained hyperglycemia

Cumulative cellular and vascular injury

Progressive organ dysfunction

Clinical manifestations

Complications often become clinically evident 15–20 years after hyperglycemia begins; Timing varies among individuals.

Slide 5 · Clinical latency does not imply absent injury

The interval before symptomatic disease is often prolonged.

Structural changes can accumulate before overt renal, retinal, or neurologic symptoms develop.

The apparent onset of a complication may occur well after the pathological process has started.

Slide 6 · Macrovascular versus microvascular disease

Feature

Macrovascular injury

Microvascular injury

Primary vessels

Large and medium arteries

Capillaries and small vessels

Characteristic process

Accelerated atherosclerosis

Basement-membrane and tissue injury

Clinical targets

Heart, brain, limbs, renal arteries

Kidney, retina, peripheral nerves

Typical consequence

Infarction or ischemia

Leakage, fibrosis, organ dysfunction

Slide 7 · The multisystem complication map

Chronic diabetes

ARTERIAL SYSTEM

MI · stroke · limb ischemia

KIDNEY

Albuminuria · renal failure

EYE

Retinopathy · visual loss

NERVES

Distal · autonomic · focal deficits

HOST DEFENSE

Skin and systemic infections

Slide 8 · Why complications occur in both major diabetes types

Type 1 diabetes produces absolute insulin deficiency through autoimmune β-cell destruction.

Type 2 diabetes combines insulin resistance with β-cell dysfunction.

Despite different upstream mechanisms, persistent hyperglycemia produces overlapping late vascular complications.

Slide 9 · Hyperglycemia is necessary context, not the whole story

Glucose exposure

Long duration and high degree of hyperglycemia promote tissue damage.

Insulin resistance

Contributes to endothelial dysfunction and atherogenic dyslipidemia.

Comorbidity

Hypertension and obesity further increase vascular stress.

Slide 10 · Four implicated metabolic injury routes

Advanced glycation

AGE formation and receptor signaling

Protein kinase C

DAG-driven signaling alterations

Polyol pathway

Sorbitol and oxidative stress

Hexosamine flux

Altered glucose-metabolite handling

Slide 11 · AGE generation alters vascular biology

Excess glucose metabolites

Nonenzymatic protein modification

Advanced glycation end products

Vascular dysfunction

AGEs arise within and outside cells and can act through RAGE, the receptor for AGEs.

Slide 12 · AGE–RAGE signaling links glucose to inflammation

Inflammatory signaling

RAGE in macrophages, T cells, and endothelium amplifies injurious responses.

Matrix remodeling

TGF-β signaling promotes excess basement-membrane material.

Vascular dysfunction

Reactive oxygen species, procoagulant activity, and smooth-muscle proliferation increase.

Slide 13 · Protein kinase C alters the vascular milieu

Intracellular hyperglycemia

Increased diacylglycerol

PKC activation

VEGF · TGF-β · PAI-1 induction

PKC effects overlap with AGE–RAGE signaling in diabetic microangiopathy.

Slide 14 · The polyol pathway consumes reducing capacity

Excess intracellular glucose

Aldose reductase converts glucose to sorbitol

NADPH consumption

Reduced antioxidant regeneration

GSH regeneration requires NADPH; Less GSH increases susceptibility to oxidative injury.

Slide 15 · Sorbitol links hyperglycemia to lens damage

Glucose enters lens

Aldose reductase produces sorbitol

Sorbitol accumulates

Lens opacity (cataract)

Conceptual simplification of the polyol contribution to diabetic cataract; Not a specimen illustration.

Slide 16 · The hexosamine pathway: A proposed contributor

Increased glucose flux diverts glycolytic intermediates through the hexosamine pathway.

This mechanism has been proposed to enhance cell injury and oxidative stress.

It may contribute to insulin resistance and vascular complications; Do not treat it as the sole mechanism.

Slide 17 · Different mechanisms converge on the microvasculature

AGEs / PKC / polyol / hexosamine

Oxidative and endothelial injury

Basement-membrane and matrix change

Retina · glomerulus · peripheral nerve

This is a conceptual synthesis; The four pathways are interacting and not a proven linear sequence.

Slide 18 · HbA1c summarizes cumulative glucose exposure

HbA1c is produced by nonenzymatic glucose addition to erythrocyte hemoglobin.

It provides a longer-term measure of glycemic exposure than a single plasma glucose value.

Prospective studies support attenuation of late end-organ damage through effective glycemic control.

Slide 19 · Glycemic control and risk reduction are related

Supported causal relationship

Greater degree and duration of hyperglycemia are associated with more severe chronic injury.

Clinical implication

Reducing sustained hyperglycemia can attenuate, although not necessarily eliminate, late complications.

Slide 20 · Macrovascular disease is accelerated atherosclerosis

Hyperglycemia + insulin resistance

Endothelial dysfunction

Accelerated atherosclerosis

Ischemia in major vascular beds

The microscopic morphology of plaques resembles nondiabetic atherosclerosis; Their accelerated occurrence is key.

Slide 21 · The principal large-vessel territories

Coronary

Atherosclerotic coronary disease → myocardial infarction.

Cerebrovascular

Large-vessel disease → cerebrovascular accidents and ischemic injury.

Peripheral

Lower-limb arterial disease → ischemia and risk of gangrene.

Slide 22 · Coronary disease carries major mortality risk

2–4×

Higher incidence of coronary artery disease

4×

Higher risk of cardiovascular death

These comparisons against age-matched individuals without diabetes.

Slide 23 · Myocardial infarction as a diabetic complication

Coronary atherosclerosis underlies a major proportion of diabetes-associated mortality.

Diabetes combines adverse vascular biology with common cardiovascular risk factors.

A myocardial infarction is a macrovascular manifestation, not a defining microangiopathic lesion.

Slide 24 · Diabetes modifies the sex pattern of infarction

Myocardial infarction occurs nearly as often in females with diabetes as in males with diabetes.

This differs from the lower incidence in reproductive-age females without diabetes.

The comparison emphasizes that diabetes markedly changes the cardiovascular risk profile.

Slide 25 · Cerebrovascular accidents belong to the vascular spectrum

Brain vascular events are major causes of death and disability in longstanding diabetes.

Accelerated atherosclerosis is an important substrate for large-vessel cerebrovascular injury.

A focal neurologic deficit should not be attributed automatically to diabetic neuropathy.

Slide 26 · Peripheral artery injury creates threatened limbs

Lower-limb atherosclerosis

Reduced tissue perfusion

Ischemic injury

Gangrene risk

Ischemia may coexist with sensory neuropathy and infection.

Slide 27 · Renal arteries and glomeruli can both be affected

Macrovascular renal injury

Atherosclerosis of larger renal arteries contributes to renal vascular insufficiency.

Microvascular renal injury

Glomerular and arteriolar disease is especially important for diabetic nephropathy.

Slide 28 · Hypertension compounds cardiovascular damage

~75%

Hypertension reported among people with type 2 diabetes

High blood pressure potentiates hyperglycemia- and insulin-resistance–associated endothelial dysfunction and atherosclerosis.

Slide 29 · Diabetic dyslipidemia is atherogenic

Lipid component

Typical direction in diabetes

Relevance

Triglycerides

Increased

Atherogenic metabolic profile

LDL cholesterol

Increased

Atherosclerotic burden

HDL cholesterol

Decreased

Reduced protective lipoprotein fraction

Slide 30 · Insulin resistance contributes to dyslipidemia

Insulin resistance

More hepatic atherogenic lipoprotein production

Less peripheral lipid uptake

Adverse circulating lipid profile

This as a likely contributor, not an exclusive explanation.

Slide 31 · Clinical vascular risk is cumulative

Hyperglycemia

Directly damages the vasculature over time.

Hypertension

Adds hemodynamic stress to already impaired endothelium.

Dyslipidemia

Favors accelerated atheromatous disease.

Slide 32 · Diabetic nephropathy has a broad clinical spectrum

Asymptomatic albuminuria

Increasing albumin excretion

Progressive renal impairment

End-stage renal disease

This is a schematic spectrum, not a guaranteed progression in every patient.

Slide 33 · Albuminuria can precede symptomatic kidney disease

The earliest recognized clinical manifestation is low-grade urinary albumin excretion.

The textbook uses “moderately increased albuminuria” instead of the older “microalbuminuria.”

A lack of symptoms should not be interpreted as absence of renal microvascular injury.

Slide 34 · Interpreting the albuminuria terminology

Older terminology

Preferred wording in source

24-hour urinary albumin

Microalbuminuria

Moderately increased albuminuria

>30 and <300 mg/day

Macroalbuminuria

Severely increased albuminuria

>300 mg/day

Slide 35 · Diabetic nephropathy is clinically consequential

30–40%

Patients with diabetes developing clinical evidence of nephropathy

The source identifies diabetic nephropathy as a leading cause of end-stage renal disease in the United States.

Slide 36 · The progression to overt nephropathy differs by type

~80%

T1D, without specific intervention

20–40%

T2D, without specific intervention

Textbook estimates for overt nephropathy developing over 10–15 years; These are historical source estimates, not individualized predictions.

Slide 37 · Hypertension and albuminuria often appear together

Overt diabetic nephropathy is often accompanied by hypertension.

Glomerular injury, arteriolar disease, and renal ischemia contribute to functional decline.

The kidney is affected by both systemic vascular risk and intrarenal microvascular damage.

Slide 38 · Glomerular basement-membrane thickening

Persistent hyperglycemia

Microangiopathic injury

Thickened glomerular basement membrane

Altered protein permeability

Basement-membrane thickening is a structural hallmark; No authentic electron micrograph was provided.

Slide 39 · Microangiopathy can cause leakage despite thickening

Morphologic finding

Capillary basement membranes thicken in diabetic microangiopathy.

Functional paradox

Capillaries nevertheless become more permeable to plasma proteins.

Slide 40 · Diffuse mesangial sclerosis

The mesangial matrix expands diffusely and is PAS-positive in tissue sections.

Greater mesangial expansion correlates with increasing proteinuria.

Progression may produce nodular mesangial deposits.

Slide 41 · Nodular sclerosis: Kimmelstiel–Wilson lesions

Rounded, frequently laminated PAS-positive nodules form in the glomerular mesangium.

This distinctive pattern occurs with widespread background diffuse mesangial sclerosis.

The nodular process is often associated with advanced renal dysfunction.

Slide 42 · Renal arteriolar hyalinosis

Afferent arteriole

Hyaline wall change contributes to altered glomerular perfusion.

Efferent arteriole

Hyalinosis is also prominent here and is particularly characteristic of diabetes.

Slide 43 · How nephron injury culminates in renal failure

Glomerular + arteriolar lesions

Progressive renal ischemia

Tubular atrophy + interstitial fibrosis

Cortical thinning / loss of function

Process schematic derived from the morphology section; Not a direct clinical timeline.

Slide 44 · Pyelonephritis is a parallel renal threat

Acute and chronic pyelonephritis are more frequent and severe in patients with diabetes.

Infection primarily affects the interstitium and tubules rather than beginning as glomerulosclerosis.

Papillary necrosis is an important associated destructive complication.

Slide 45 · Renal vascular injury versus renal infection

Feature

Diabetic nephropathy

Pyelonephritis

Principal injury

Glomeruli, microvessels, renal parenchyma

Infection-related interstitial and tubular inflammation

Common consequence

Albuminuria and chronic renal decline

Acute or chronic infectious injury

Characteristic context

Glomerulosclerosis / arteriolar hyalinosis

Greater susceptibility and severity in diabetes

Slide 46 · The eye has three major diabetes-associated pathways

Retina

Microvascular retinopathy threatens central visual function.

Lens

Hyperglycemia promotes opacification and cataract.

Optic nerve

Glaucoma-related pressure injury contributes to impairment.

Slide 47 · Diabetic retinopathy: A major cause of visual loss

60–80%

Estimated to develop some form of diabetic retinopathy

Diabetic retinopathy as a leading cause of adult blindness in the United States.

Slide 48 · Retinopathy has nonproliferative and proliferative forms

Background / nonproliferative

Earlier retinal vasculopathy without the defining new-vessel growth of proliferative disease.

Proliferative

Retinal hypoxia–associated VEGF signaling drives pathologic neovascularization.

Slide 49 · Retinal hypoxia drives VEGF release

Diabetic retinal vascular injury

Relative tissue hypoxia

VEGF expression

Pathologic neovascularization

VEGF: Vascular endothelial growth factor; This diagram represents the proliferative pathway.

Slide 50 · Why neovascularization matters to vision

New vessel formation reflects maladaptive responses to retinal hypoxia.

It is a characteristic advanced retinopathy mechanism highlighted by Robbins.

The clinical endpoint is progressive visual impairment and potentially blindness.

Slide 51 · Anti-VEGF treatment targets a causal mediator

Hypoxia-induced VEGF

VEGF-dependent neovascular response

Antiangiogenic treatment blocks VEGF action

Suppression of pathologic vessel signaling

Therapeutic mechanism only; No regimen, dose, or treatment-selection criteria implied.

Slide 52 · Cataracts and glaucoma are not retinopathy

Condition

Primary tissue/process

Clinical outcome

Cataract

Lens opacity associated with hyperglycemia

Visual impairment

Glaucoma

Elevated intraocular pressure and optic nerve injury

Visual impairment

Retinopathy

Retinal microvascular injury ± neovascularization

Visual impairment or blindness

Slide 53 · Neuropathy can affect several neural compartments

Distal peripheral nerves

Most frequent presentation; Sensorimotor polyneuropathy.

Autonomic nerves

Bowel, bladder, and sexual-function disturbances.

Individual nerves

Mononeuropathy with a localized motor or cranial-nerve deficit.

Slide 54 · Distal symmetric polyneuropathy is the usual pattern

Chronic diabetes

Peripheral nerve damage

Distal lower-extremity deficits

Possible upper-extremity extension

The usual distribution becomes a stocking-and-glove pattern over time.

Slide 55 · The stocking-and-glove pattern has clinical meaning

Distal symptoms commonly begin in the feet and lower legs.

Upper-extremity involvement may develop later, producing a glove-and-stocking distribution.

The pattern is typically bilateral and symmetric, unlike isolated focal mononeuropathy.

Slide 56 · Neuropathy affects both sensory and motor function

Sensory involvement

Distal sensory deficits may interfere with detection of minor injuries.

Motor involvement

Peripheral sensorimotor injury may impair motor function and mobility.

Slide 57 · Autonomic neuropathy causes visceral dysfunction

Gastrointestinal

Disturbances of bowel function.

Urinary

Bladder dysfunction.

Genitourinary

Erectile dysfunction in some patients.

Slide 58 · Mononeuropathy creates focal clinical deficits

Presentation

Pattern

Interpretation

Footdrop

Focal lower-limb motor deficit

Possible diabetic mononeuropathy

Wristdrop

Focal upper-limb motor deficit

Possible diabetic mononeuropathy

Cranial nerve palsy

Isolated cranial deficit

Possible diabetic mononeuropathy

Slide 59 · Sensory loss changes the significance of a minor wound

Distal neuropathy

Minor toe injury may be unnoticed

Local infection develops

Complication can progress

Clinical conceptual sequence; Diabetic vascular compromise worsens local host defense.

Slide 60 · Diabetes increases susceptibility to several infections

Skin and soft tissue

Local infection may initiate a severe limb complication.

Respiratory

Pneumonia and tuberculosis are emphasized in the source.

Urinary tract

Pyelonephritis is more common and often more severe.

Slide 61 · Neutrophil dysfunction contributes to infection risk

Chemotaxis

Abnormal migration toward infection

Adhesion

Impaired endothelial interaction

Phagocytosis

Reduced microbial ingestion

Killing

Impaired microbicidal activity

Slide 62 · Host-defense impairment is multifactorial

Defective neutrophil function

Altered macrophage cytokine production

Vascular delivery impairment

Susceptibility / greater infection severity

Multiple parallel contributing processes are shown in a linear layout for clarity; Not a strict biochemical sequence.

Slide 63 · Vascular compromise limits immune-cell delivery

Compromised vascular supply restricts access of defensive cells and soluble immune components.

A local infection may become difficult to contain when circulation is impaired.

Vascular injury and leukocyte functional impairment reinforce one another.

Slide 64 · A diabetic toe infection can become systemic

Minor toe infection

Gangrene / progressive local injury

Bacteremia

Severe systemic consequences

Adapted from the illustrative clinical cascade; Not a deterministic patient trajectory.

Slide 65 · The diabetic limb problem is a three-way interaction

NEUROPATHY

Impaired injury detection

VASCULAR INJURY

Reduced tissue perfusion

INFECTION

Defective local defense

All three factors may contribute to the escalation of a minor foot lesion.

Slide 66 · Case: Painless toe wound with spreading infection

A person with long-standing diabetes does not notice a small toe injury. Local infection progresses while the foot shows evidence of poor perfusion.

Which two chronic complications explain the vulnerability?

How can infection progress beyond the initial lesion?

Clinicopathologic interpretation

Distal neuropathy reduces awareness of injury; Arterial compromise and impaired leukocyte responses hinder containment.

Slide 67 · Case: Asymptomatic urinary albumin excretion

A person with long-standing diabetes feels well but has persistently increased urinary albumin excretion and newly documented hypertension.

Why can kidney damage be clinically silent at first?

What tissue lesions explain the albumin leak?

Clinicopathologic interpretation

Early diabetic nephropathy can manifest through albuminuria before symptoms; Glomerular microangiopathy and mesangial changes alter permeability.

Slide 68 · Case: Deteriorating sight in longstanding diabetes

A patient with years of hyperglycemia develops progressive visual impairment and retinal neovascularization is documented.

What drives the new vessel formation?

What treatment target is linked to this mechanism?

Clinicopathologic interpretation

Retinal hypoxia induces VEGF; Antiangiogenic agents can block VEGF-dependent signaling.

Slide 69 · Case: Focal weakness versus distal neuropathy

Two people with diabetes present differently: One has bilateral distal foot sensory loss; Another develops sudden unilateral footdrop.

Which presentation fits distal symmetric polyneuropathy?

Which presentation suggests mononeuropathy?

Clinicopathologic interpretation

Bilateral distal loss fits polyneuropathy; An abrupt focal deficit is compatible with mononeuropathy, although alternative causes need clinical assessment.

Slide 70 · Clinical clues localize diabetic complications

Clue

Probable organ system

Pathologic framework

Myocardial infarction / stroke

Large arteries

Accelerated atherosclerosis

Urinary albumin

Renal glomeruli

Microangiopathy / glomerulosclerosis

Retinal neovascularization

Retina

Hypoxia / VEGF signaling

Distal symmetric sensory loss

Peripheral nerves

Diabetic polyneuropathy

Recurrent severe infection

Immune system / tissue perfusion

Cellular and vascular host-defense defects

Slide 71 · Clinical complications need simultaneous assessment

Vascular events, kidney injury, eye disease, neuropathy, and infection susceptibility coexist in the same chronic disease.

Recognition of one manifestation should increase attention to other end-organ compartments.

Clinical features should be interpreted with exposure duration and concomitant vascular risks.

Slide 72 · Long-term glycemic management has organ-level consequences

Reduction of chronic exposure

Effective control of hyperglycemia attenuates development of late end-organ injury.

Limits of glucose-only thinking

Insulin resistance, blood pressure, dyslipidemia, and obesity also affect complication risk.

Slide 73 · Integrated mechanistic synthesis

Longstanding hyperglycemia

Metabolic + endothelial injury

Large- and small-vessel disease

Cardiovascular · renal · ocular · neural injury

Host-defense dysfunction and infection can amplify morbidity at any point.

Slide 74 · Summary: Five clinical domains

Vascular

Myocardial infarction, stroke, limb ischemia.

Renal

Albuminuria progressing to glomerulosclerosis and renal failure.

Ocular

Retinopathy, cataracts, glaucoma, visual loss.

Neural

Distal symmetric, autonomic, or focal neuropathy.

Infectious

Impaired leukocytes plus compromised vascular delivery.

Slide 75 · References and interpretation

Primary teaching source: Robbins, Cotran & Kumar, Pathologic Basis of Disease, 11th ed. (2026), Chapter 24, pp. 1006–1011.

Core scope: “Clinical Manifestations of Chronic Diabetes”; mechanistic and morphologic context from adjacent diabetes sections.

Numerical estimates are textbook-reported and should not be assumed to represent current population-specific risk.

All diagrams are native PowerPoint schematics; no textbook photomicrographs are reproduced.